Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Cancers|October 13, 2021
Anti-GD2 Based Immunotherapy Prevents Late Events in High-Risk Neuroblastoma Patients over 18 Months at DiagnosisMichelle L Tas, Lisa W Dootjes, Marta Fiocco, et al.
Journal of Pediatric Surgery|November 13, 2018
Incidence, severity and outcome of central line related complications in pediatric oncology patients; A single center studyCeder H van den Bosch, J Tjomme van der Bruggen, Florine N J Frakking, et al.
Blood|February 27, 2008
The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemiaPieter Van Vlierberghe, Martine van Grotel, Joëlle Tchinda, et al.
Cancer Reports (Hoboken, N.J.)|November 26, 2024
A Retrospective Evaluation of Ototoxicity Monitoring in a Cohort of Pediatric Patients With Solid Tumors, Treated in the Dutch National Cancer CenterFranciscus A Diepstraten, Odette M M Bertram, Hiske W Helleman, et al.
BMJ Paediatrics Open|June 3, 2021
Daily life participation in childhood chronic disease: a qualitative study on the child's and parent's perspectiveMerel M Nap-van der Vlist, Emma E Berkelbach van der Sprenkel, Linde N Nijhof, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2016
Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects studyEva Clemens, Andrica C de Vries, Saskia F Pluijm, et al.
JCO Precision Oncology|March 12, 2026
Effect of MYCN Amplification on Tumor Response and Recurrence in Patients With Stage IV NeuroblastomaYvette A H Matser, André B P van Kuilenburg, Atia Samim, et al.
Pediatric Hematology and Oncology|June 8, 2017
Hearing loss after platinum treatment is irreversible in noncranial irradiated childhood cancer survivorsEva Clemens, Andrica Ch de Vries, Antoinette Am Zehnhoff-Dinnesen, et al.
Pageof 8